PATHOQUEST
PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of pathogen detection. The company’s proprietary next generation sequencing (NGS) based testing approach delivers actionable reports to clinicians, biologists and biopharmaceutical quality assurance managers/production managers. PathoQuest’s proprietary sample preparation, and its comprehensive database of pathogens genomic information, enables c... linicians and biopharma companies to overcome the current limitation of infectious agent detection. PathoQuest’s Viral Safety testing service, directed towards biopharmaceutical companies, is the company’s first commercial application of its testing approach and has quickly established a revenue stream for the company from several major biopharma companies.
PATHOQUEST
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.pathoquest.com
Total Employee:
11+
Status:
Active
Contact:
+33 170 821 790
Email Addresses:
[email protected]
Total Funding:
34.8 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins
Current Employees Featured
Founder
Investors List
Turenne Capital
Turenne Capital investment in Series B - PathoQuest
Eurazeo
Eurazeo investment in Series B - PathoQuest
Aurinvest
Aurinvest investment in Series B - PathoQuest
Kurma Partners
Kurma Partners investment in Series B - PathoQuest
SHS Capital
SHS Capital investment in Series B - PathoQuest
Verve Ventures
Verve Ventures investment in Series B - PathoQuest
Charles River Laboratories International
Charles River Laboratories International investment in Series B - PathoQuest
Fraser
Fraser investment in Venture Round - PathoQuest
Verve Ventures
Verve Ventures investment in Venture Round - PathoQuest
Norgine Ventures
Norgine Ventures investment in Venture Round - PathoQuest
Newest Events participated
Participated in BioProcess International European Summit 2017
on 2017-04-25 as exhibitor
Participated in Viral Safety 2017
on 2017-04-25 as exhibitor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as exhibitor
Official Site Inspections
http://www.pathoquest.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "PathoQuest"
About company | PathoQuest
Sep 25, 2024 PathoQuest drives innovation in quality testing to deliver new biotherapies …See details»
Modalities - PathoQuest
PathoQuest, in partnership with Charles River Laboratories, is the first Contract Research Organization (CRO) to conclusively demonstrate the superiority of NGS-based biosafety testing over conventional in vivo testing methods for …See details»
PathoQuest - Crunchbase Company Profile & Funding
PathoQuest SAS, a spin off of Institut Pasteur, is a biotechnology company offering a game changing metagenomics approach to improving the breadth of …See details»
Company profile | PathoQuest | My Biologics Partner
PathoQuest is a global CRO that specializes in biologics quality testing based on next …See details»
PathoQuest - LinkedIn
PathoQuest is a global CRO providing NGS-based Quality Control testing through its iDTECT® platform of assays for rapid and safe release of biotherapies to patients.See details»
PathoQuest - LinkedIn
PathoQuest | 3,159 followers on LinkedIn. A global CRO providing NGS-based Quality Control …See details»
PathoQuest Receives GMP Certification for Its NGS …
Nov 24, 2021 PARIS--(BUSINESS WIRE)--PathoQuest, a leading contract research organization (CRO) for the biosafety testing of biologics with Next-Generation Sequencing (NGS) technologies, today announced that ...See details»
Why Partner With PathoQuest | PathoQuest
With a proven track record in biotesting, PathoQuest offers a team of NGS Quality Control …See details»
PathoQuest - Funding, Financials, Valuation & Investors
PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive …See details»
Leadership Team - PathoQuest
PathoQuest's leadership team brings an extensive experience in the Pharmaceutical and CRO/CDMO industry with successful leading roles in international. ... (TFS) in 1996, which became a world-leading midsized global …See details»
PathoQuest opens US facility to provide NGS biosafety …
Oct 25, 2022 PathoQuest has built the facility at Charles River Laboratories' site in Wayne, Pennsylvania, reflecting the strategic partnership between the two companies. The CRO entered into a strategic partnership with PathoQuest in …See details»
PathoQuest Company Profile 2024: Valuation, Funding & Investors …
Nov 13, 2017 PathoQuest General Information Description. Developer of a molecular …See details»
PathoQuest Company Profile - Office Locations, Competitors
PathoQuest is a molecular diagnostics company that offers an approach to improving pathogen …See details»
PathoQuest Receives GMP Certification for Its NGS-based Quality …
Nov 24, 2021 PathoQuest, a leading contract research organization (CRO) for the biosafety …See details»
PathoQuest Announce the Opening of its New U.S. Facility
Oct 4, 2022 PathoQuest is headquartered in Paris, France, and has worked with over 100 of …See details»
Oxford Nanopore and PathoQuest announce the first steps in a …
Mar 21, 2023 PathoQuest offers biopharmaceutical companies a game-changing genomic …See details»
GMP Next Generation Sequencing (NGS) | Services - PathoQuest
The PathoQuest mission is to develop proprietary, rapid turn-around-time GMP Next …See details»
PathoQuest - Overview, News & Similar companies | ZoomInfo.com
Sep 6, 2023 PathoQuest's technology combines an NGS platform with proprietary sample …See details»
A Blood Test That Uses Next-Generation Sequencing - Nanalyze
Mar 30, 2020 The World Health Organization has noted that new cases of multidrug-resistant …See details»
Charles River and PathoQuest Announce Publication of a Head-to …
This project was funded by Charles River and PathoQuest, understanding the importance of …See details»